Skip to content

Revvity RVTY Free cash flow

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Danaher logo
DanaherDHR
$1.09B+2.9%
WAT
Waters CorporationWAT
-$42M-118%
Agilent Technologies logo
Agilent TechnologiesA
$201M+87.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Illumina logo
IlluminaILMN

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Calculated from Revvity’s reported figures.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's free cash flow?
Revvity (RVTY) reported free cash flow of $95.46M in Q1 2026.
How has Revvity's free cash flow changed year-over-year?
Revvity's free cash flow decreased by 14.9% year-over-year, from $112.17M to $95.46M.
What is the long-term trend for Revvity's free cash flow?
Over 4 years (2021 to 2025), Revvity's free cash flow has grown at a -21.3% compound annual growth rate (CAGR), from $1.32B to $509.41M.